Sign Up Today and Learn More About INDIGO Biosciences Stock
Invest in or calculate the value of your shares in INDIGO Biosciences or other pre-IPO companies through EquityZen's platform.
INDIGO Biosciences Stock (INOB)
INDIGO Biosciences offers products and services on nuclear receptors, which comprise of therapeutic drug targets.
About INDIGO Biosciences Stock
Founded
2005
Headquarters
Kelayres, PA, US
Industries
Science and Engineering, Health Care, Biotechnology
INDIGO Biosciences Press Mentions
Stay in the know about the latest news on INDIGO Biosciences
INDIGO Biosciences Launches Dopamine Receptor D1 Reporter Assay for Neurological and Psychiatric Research
einpresswire • Mar 11, 2025
INDIGO Biosciences Launches Cell-Based Luciferase Reporter Assay for Human Glucagon Receptor (GCGR)
einpresswire • Jan 28, 2025
INDIGO Biosciences Launches Family of FGFR4 Reporter Assays for Accelerated Cancer and Muscle Disease Research
einpresswire • Nov 14, 2024
INDIGO Biosciences Launches New Cell-Based Luciferase Reporter Assay for the Human Melanocortin 2 Receptor (MC2R)
einpresswire • Sep 24, 2024
INDIGO Biosciences Announces Launch of Their New Website
einpresswire • Aug 24, 2023
INDIGO Biosciences Management
Leadership team at INDIGO Biosciences
CFO
Bob Culhane
Chief Scientific Officer
Jack Vanden Heuvel
Join now and verify your accreditation status to gain access to:
- INDIGO Biosciences Current Valuation
- INDIGO Biosciences Stock Price
- INDIGO Biosciences Management
- Available deals in INDIGO Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- INDIGO Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- INDIGO Biosciences Revenue and Financials
- INDIGO Biosciences Highlights
- INDIGO Biosciences Business Model
- INDIGO Biosciences Risk Factors
- INDIGO Biosciences Research Report from SACRA Research
Trading INDIGO Biosciences Stock
How to invest in INDIGO Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like INDIGO Biosciences through EquityZen funds. These investments are made available by existing INDIGO Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell INDIGO Biosciences stock?
Shareholders can sell their INDIGO Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
